PUBLIC COMPANY
saveTaiho Oncology Inc
updated 1mo ago
community read0 votes
pipeline
5
marketed
2
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(5)
pipeline depth5 products
1Phase 11Phase 32Marketed1Unknown
Marketed
(tipiracil hydrochloride + trifluridine)
Adenocarcinoma Of The Gastroesophageal Junction
Marketedfutibatinib
Bile Duct Cancer (Cholangiocarcinoma)
Fibroblast growth factor receptor
Phase 3(azacitidine + cedazuridine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Phase 1TAS-2940
Solid Tumor
drugLYTGOBI
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that